SageGuard Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.44M Buy
4,536
+1,042
+30% +$1.06M 0.76% 45
2026
Q1
$3.21M Buy
3,494
+2,236
+178% +$2.27M 0.5% 55
2025
Q4
$1.35M Buy
+1,258
New +$1.2M 0.22% 80
2021
Q3
Sell
-1,455
Closed -$334K 77
2021
Q2
$334K Sell
1,455
-8
-0.5% -$1.61K 0.15% 101
2021
Q1
$274K Sell
1,463
-32
-2% -$6.26K 0.13% 107
2020
Q4
$254K Buy
+1,495
New +$223K 0.12% 104

Other funds holding LLY

SageGuard Financial Group's LLY Position: Q2 2026 in Review

SageGuard Financial Group increased its Eli Lilly (LLY) stake by 30% in Q2 2026, buying an estimated $1.06M and bringing the position to 4,536 shares worth $5.44M. The position accounts for 0.76% of the portfolio, ranked #45.

SageGuard Financial Group first reported a position in LLY in Q4 2020 and has held it in 6 quarters since. 3,023 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SageGuard Financial Group held 4,536 shares of Eli Lilly worth $5.44M as of Q2 2026.
  • SageGuard Financial Group bought 1,042 Eli Lilly shares in Q2 2026, an estimated $1.06M.
  • Eli Lilly made up 0.76% of SageGuard Financial Group's portfolio in Q2 2026, its #45 holding.
  • SageGuard Financial Group first reported a position in Eli Lilly in Q4 2020 and has held it in 6 quarters since.
  • 3,023 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SageGuard Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.